Candriam Equities L Oncology Fund Class SF2 EUR Acc
ISIN LU2295688928 / Valor 11032003
Candriam Equities L Oncology Fund Class SF2 EUR Acc
UMushroom community rating:
Candriam Equities L Oncology Fund invests globally in companies dedicated to cancer research, diagnosis, treatment, and related technologies. The portfolio includes firms engaged in developing innovative therapies, diagnostic tools, medical equipment, and specialized services that address various aspects of oncology. Selection is based on each company's significant involvement in the fight against cancer, the quality of their clinical data, and strong fundamental attributes like effective management, growth potential, and competitive strengths. By focusing on these criteria, the fund aims to achieve capital growth while supporting advancements in cancer care and treatment.
Ratings & reviews
OTHER SHARE CLASSES OF THIS FUND
